NIDA Core "Center of Transformative Science" Grant Program
National Institutes of Health
Classification and identifiers
- Solicitation number
- PAR-27-097
- Assistance listing (CFDA)
- 93.279
Amount
Amount not published by the funder
Who can apply
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
About this opportunity
The National Institute on Drug Abuse (NIDA) seeks to advance its mission by supporting Core Center of Transformative Science Grants. These Centers will bring together investigators currently funded by NIH or other Federal or non-Federal sources to enhance and extend existing research relevant to substance use, addiction, and HIV. Centers are expected to transform the scientific field of study by facilitating research, providing administrative support, and fostering a rigorous research environment that encourages innovative and creative directions. Incremental work should not be the focus of Center activities. Applications responding to this Notice of Funding Opportunity (NOFO) are strongly encouraged to integrate and promote research across funded projects at the applicant institution that...
Related opportunities
- Collaborative Program Grant for Multidisciplinary TeamsNational Institutes of Health
- Translational Centers Using Microphysiologic Systems for Infectious DiseasesNational Institutes of Health
- Cooperative Program for Modeling Clinical TransplantationNational Institutes of Health
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)National Institutes of HealthCloses Nov 2026Up to $750K
- Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)National Institutes of HealthCloses Aug 2027Up to $150K
- Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)National Institutes of HealthCloses Apr 2027